Literature DB >> 24423348

Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).

Julia K Bickmann1, Stefanie Sollfrank, Arno Schad, Thomas J Musholt, Erik Springer, Matthias Miederer, Oliver Bartsch, Konstantinos Papaspyrou, Dimitrios Koutsimpelas, Wolf J Mann, Matthias M Weber, Karl J Lackner, Heidi Rossmann, Christian Fottner.   

Abstract

CONTEXT: Mutations in the four subunits of succinate dehydrogenase (SDH) are the cause for the hereditary paraganglioma (PGL) syndrome types 1-4 and are associated with multiple and recurrent pheochromocytomas and PGLs. SDHC mutations most frequently result in benign, nonfunctional head-and neck PGLs (HNPGLs). The malignant potential of SDHC mutations remains unclear to date.
OBJECTIVES: We report a patient with malignant PGL carrying a SDHC mutation and compare her case with two others of the same genotype but presenting with classic benign HNPGLs. Loss of heterozygosity (LOH) was demonstrated in the malignant PGL tissue.
DESIGN: In three unrelated patients referred for routine genetic testing, SDHB, SDHC, and SDHD genes were sequenced, and gross deletions were excluded by multiplex ligation-dependent probe amplification (MLPA). LOH was determined by pyrosequencing-based allele quantification and SDHB immunohistochemistry.
RESULTS: In a patient with a nonfunctioning thoracic PGL metastatic to the bone, the lungs, and mediastinal lymph nodes, we detected the SDHC mutation c.397C>T predicting a truncated protein due to a premature stop codon (p.Arg133*). We demonstrated LOH and loss of SDHB protein expression in the malignant tumor tissue. The two other patients also carried c.397C>T, p.Arg133*; they differed from each other with respect to their tumor characteristics, but both showed benign HNPGLs.
CONCLUSIONS: We describe the first case of a malignant PGL with distant metastases caused by a SDHC germline mutation. The present case shows that SDHC germline mutations can have highly variable phenotypes and may cause malignant PGL, although malignancy is probably rare.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24423348     DOI: 10.1210/jc.2013-3486

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.

Authors:  Florian Haller; Evgeny A Moskalev; Fabio R Faucz; Sarah Barthelmeß; Stefan Wiemann; Matthias Bieg; Guillaume Assie; Jerome Bertherat; Inga-Marie Schaefer; Claudia Otto; Eleanor Rattenberry; Eamonn R Maher; Philipp Ströbel; Martin Werner; J Aidan Carney; Arndt Hartmann; Constantine A Stratakis; Abbas Agaimy
Journal:  Endocr Relat Cancer       Date:  2014-05-23       Impact factor: 5.678

Review 2.  PRECISION MEDICINE: AN UPDATE ON GENOTYPE/BIOCHEMICAL PHENOTYPE RELATIONSHIPS IN PHEOCHROMOCYTOMA/PARAGANGLIOMA PATIENTS.

Authors:  Garima Gupta; Karel Pacak
Journal:  Endocr Pract       Date:  2017-03-23       Impact factor: 3.443

Review 3.  Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.

Authors:  Judith Favier; Laurence Amar; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

4.  A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL.

Authors:  Isabelle Bourdeau; Solange Grunenwald; Nelly Burnichon; Emmanuel Khalifa; Nadine Dumas; Marie-Claire Binet; Serge Nolet; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Endocrinol Metab       Date:  2016-10-04       Impact factor: 5.958

Review 5.  Genetics of Tinnitus: Still in its Infancy.

Authors:  Barbara Vona; Indrajit Nanda; Wafaa Shehata-Dieler; Thomas Haaf
Journal:  Front Neurosci       Date:  2017-05-08       Impact factor: 4.677

Review 6.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

7.  Prevalence of clinically actionable disease variants in exceptionally long-lived families.

Authors:  Paige Carlson; Mary K Wojczynski; Todd Druley; Joseph H Lee; Joseph M Zmuda; Bharat Thyagarajan
Journal:  BMC Med Genomics       Date:  2020-04-10       Impact factor: 3.063

8.  A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With an SDHC Germline Mutation.

Authors:  Raquel Kristin S Ong; Shahida K Flores; Robert L Reddick; Patricia L M Dahia; Hassan Shawa
Journal:  J Clin Endocrinol Metab       Date:  2018-08-01       Impact factor: 5.958

Review 9.  Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Authors:  Rute Martins; Maria João Bugalho
Journal:  Int J Endocrinol       Date:  2014-05-12       Impact factor: 3.257

10.  Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD.

Authors:  Katrina A Andrews; David B Ascher; Douglas Eduardo Valente Pires; Daniel R Barnes; Lindsey Vialard; Ruth T Casey; Nicola Bradshaw; Julian Adlard; Simon Aylwin; Paul Brennan; Carole Brewer; Trevor Cole; Jackie A Cook; Rosemarie Davidson; Alan Donaldson; Alan Fryer; Lynn Greenhalgh; Shirley V Hodgson; Richard Irving; Fiona Lalloo; Michelle McConachie; Vivienne P M McConnell; Patrick J Morrison; Victoria Murday; Soo-Mi Park; Helen L Simpson; Katie Snape; Susan Stewart; Susan E Tomkins; Yvonne Wallis; Louise Izatt; David Goudie; Robert S Lindsay; Colin G Perry; Emma R Woodward; Antonis C Antoniou; Eamonn R Maher
Journal:  J Med Genet       Date:  2018-01-31       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.